Antibiotice Ia (ATB) — Working Capital to Net Assets Ratio
Antibiotice Ia (ATB) has a Working Capital to Net Assets ratio of 13.1% as of June 2026. Working capital of RON121.56 Million (current assets of RON608.85 Million minus current liabilities of RON487.29 Million) is measured against net assets of RON930.75 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Antibiotice Ia Working Capital to Net Assets (2020–2025)
This chart shows how Antibiotice Ia's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 13.1%, reflecting working capital of RON121.56 Million against net assets of RON930.75 Million RON. See Antibiotice Ia (ATB) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Antibiotice Ia (2020–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Antibiotice Ia from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ATB current and non-current assets.
| Year | WC/NA Ratio | Working Capital (RON) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 27.4% | RON255.33 Million | RON932.07 Million | RON505.69 Million | RON250.36 Million | ▲ +0.6 pp |
| 2024 | 26.8% | RON239.64 Million | RON894.31 Million | RON474.69 Million | RON235.06 Million | ▲ +1.9 pp |
| 2023 | 24.9% | RON210.81 Million | RON846.96 Million | RON401.28 Million | RON190.47 Million | ▼ -4.5 pp |
| 2022 | 29.4% | RON188.53 Million | RON641.43 Million | RON323.87 Million | RON135.34 Million | ▼ -1.3 pp |
| 2021 | 30.7% | RON185.87 Million | RON604.99 Million | RON385.01 Million | RON199.14 Million | ▼ -2.0 pp |
| 2020 | 32.7% | RON188.71 Million | RON577.27 Million | RON375.41 Million | RON186.70 Million | — |